Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

'Innovation needed' in animal vaccines
vaccine
The report considers the barriers to modern vaccine use, including the regulatory process.
New report considers barriers to modern vaccine use

Vaccination is seen as the biggest breakthrough in animal health in the last 100 years, according to a recent survey, but leading experts say greater innovation is needed to improve outcomes.

A new report authored by Oxford Analytica examines the future of the animal health sector, based on discussions held at a recent HealthforAnimals roundtable meeting.

Among other topical issues, the report considers the barriers to modern vaccine use, including the regulatory process. While such barriers can often be overcome in an emergency, the system as a whole needs to be streamlined, the Innovation in animal health report says.

'Coopetition' is something that is already happening in other sectors and authors say this could have a place in developing vaccine technology. It is cooperation between companies that share a goal, as well as the risks, costs and data.

In the case of the 2014 Schmallenberg outbreak, many companies were cautious about investing in vaccine innovation until several companies undertook similar projects in parallel. According to the report, coopetition would allow for quicker vaccine development and is a better use of funding.

Gregorio Torres from the World Organisation for Animal Health (OIE) advocates a greater allocation of funding for vaccine banks which hold ready-to-use vaccines and/or antigen components that can be formulated as needed.

To improve management of these banks, OIE has created a new concept of virtual rolling stocks. Selected suppliers would produce vaccines on demand or they remain with suppliers at their own risk and are renewed on a rolling basis.

Dr Torres said this strategy is very important for the timely procurement of high quality vaccines.

Commenting on the report's conclusions, Carel du Marchie Sarvaas from HealthforAnimals, said: "Vaccination has profoundly influenced and improved the health of both animals and people globally, and it will continue to be a fundamental tool to meet future health challenges.

"It has eliminated smallpox in people and can control many other diseases against which no other treatment exists, such as human polio, foot-and-mouth disease in cattle and rabies in people and animals.

"Prevention is better than cure so it is vital we inject innovation into this field to ensure its growth."

Innovation in animal health also explores other topics highlighted by the roundtable discussion, including food safety and sustainability, zoonotic and vector-borne disease and innovation in pet health. Read the full report here: http://healthforanimals.org/innovation-in-animal-health/

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.